You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》巨子生物(02367.HK)公開發售下限定價24.3元 一手中籤率100%
阿思達克 11-03 10:08
內地基於生物活性成分的專業皮膚護理產品生產商巨子生物(02367.HK)公布招股結果,每股發售價定為24.3元,為招股價範圍(24.3至27.7元)的下限定價。香港公開發售錄得超購約1.08倍。每手200股計,一手中籤率100%人人有份。該股將於明日(4日)掛牌。聯席保薦人為高盛及中金。 公司上市料淨集資約4.96億元,當中約11%擬用於研發投資以通過招聘擴大研發團隊、擴展研發設施及進行測試和驗證研究;約28%將用於擴展與公司產品組合及生物活性成分有關的生產能力;約46%將用於增強全渠道銷售及經銷網絡,並開展以科學和知識為導向的營銷活動以提高品牌知名度;約5%將用於提升營運及信息系統,約10%用作營運資金及一般公司用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account